XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
BIDU-SW
09888
KUAISHOU-W
01024
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -23.63%2.87B | ---- | 8.86%3.76B | ---- | 22.74%3.46B | ---- | 13.20%2.82B | ---- | 23.99%2.49B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -38.82%-146.48M | ---- | -28.91%-105.52M | ---- | -34.12%-81.85M | ---- | -45.32%-61.03M | ---- | -61.06%-42M |
Interest expense - adjustment | ---- | -5.78%46.25M | ---- | 73.63%49.09M | ---- | 2.73%28.27M | ---- | -51.08%27.52M | ---- | -21.74%56.26M |
Dividend (income)- adjustment | ---- | ---30.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | -327.08%-277.87M | ---- | 13.66%-65.06M | ---- | 51.01%-75.35M | ---- | -34.57%-153.8M | ---- | -37.94%-114.29M |
Impairment and provisions: | ---- | 423.04%324.88M | ---- | 191.54%62.11M | ---- | -90.64%21.31M | ---- | 3,897.86%227.6M | ---- | 226.25%5.69M |
-Impairmen of inventory (reversal) | ---- | --33.22M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | ---- | ---- | 200.00%60M | ---- | -88.24%20M | ---- | --170M | ---- | ---- |
-Other impairments and provisions | ---- | 13,703.12%291.66M | ---- | 61.92%2.11M | ---- | -97.73%1.31M | ---- | 911.73%57.6M | ---- | 226.25%5.69M |
Revaluation surplus: | ---- | 134.67%66.54M | ---- | -81.73%-191.9M | ---- | -833.59%-105.59M | ---- | 261.66%14.39M | ---- | 46.75%-8.9M |
-Derivative financial instruments fair value (increase) | ---- | 218.85%49.79M | ---- | -516.27%-41.89M | ---- | -27.22%10.06M | ---- | 255.29%13.83M | ---- | 46.75%-8.9M |
-Other fair value changes | ---- | 111.17%16.75M | ---- | -29.70%-150.01M | ---- | -20,497.88%-115.66M | ---- | --567K | ---- | ---- |
Asset sale loss (gain): | ---- | -34.24%265K | ---- | 79.11%403K | ---- | 55.17%225K | ---- | -94.92%145K | ---- | 68.18%2.85M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -34.24%265K | ---- | 79.11%403K | ---- | 55.17%225K | ---- | -98.41%145K | ---- | 437.54%9.12M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.27M |
Depreciation and amortization: | ---- | 1.03%229.57M | ---- | 4.28%227.23M | ---- | 5.57%217.89M | ---- | 2.11%206.39M | ---- | 1.57%202.13M |
-Amortization of intangible assets | ---- | -1.37%163.5M | ---- | 0.96%165.77M | ---- | 1.39%164.2M | ---- | -0.23%161.94M | ---- | -2.37%162.32M |
-Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | 0.00%-1.93M | ---- | 0.00%-1.93M | ---- | ---1.93M |
Exchange Loss (gain) | ---- | -102.24%-3.49M | ---- | 1,843.40%155.74M | ---- | 130.03%8.01M | ---- | -188.14%-26.68M | ---- | -43.00%30.28M |
Special items | ---- | -291.66%-35.87M | ---- | 9.09%18.72M | ---- | --17.16M | ---- | ---- | ---- | -91.45%2.95M |
Operating profit before the change of operating capital | ---- | -22.15%3.05B | ---- | 12.25%3.91B | ---- | 14.29%3.49B | ---- | 16.32%3.05B | ---- | 16.95%2.62B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -2,990.72%-235.77M | ---- | 108.98%8.16M | ---- | -451.60%-90.87M | ---- | 4.82%25.84M | ---- | 148.10%24.66M |
Accounts receivable (increase)decrease | ---- | 112.00%330.46M | ---- | 132.43%155.88M | ---- | -159.23%-480.65M | ---- | -238.88%-185.42M | ---- | 153.52%133.51M |
Accounts payable increase (decrease) | ---- | -15.29%-82.85M | ---- | -112.18%-71.86M | ---- | -113.74%-33.87M | ---- | 2,716.92%246.49M | ---- | 87.54%-9.42M |
Special items for working capital changes | ---- | -322.70%-8.88M | ---- | -122.57%-2.1M | ---- | 534.56%9.31M | ---- | -80.36%1.47M | ---- | 856.07%7.47M |
Cash from business operations | ---- | -23.82%3.05B | ---- | 38.51%4B | ---- | -7.91%2.89B | ---- | 12.96%3.14B | ---- | 48.98%2.78B |
Hong Kong profits tax paid | ---- | -366.39%-569K | ---- | 94.79%-122K | ---- | 65.37%-2.34M | ---- | -461.76%-6.76M | ---- | 60.53%-1.2M |
China income tax paid | ---- | -37.73%-391.92M | ---- | -5.99%-284.57M | ---- | -57.77%-268.48M | ---- | 23.52%-170.18M | ---- | -106.63%-222.51M |
Other taxs | ---- | 6.78%-154.56M | ---- | -31.69%-165.81M | ---- | 53.37%-125.9M | ---- | -642,838.10%-270.03M | ---- | ---42K |
Special items of business | -41.45%872.87M | ---- | 2.68%1.49B | ---- | 1.20%1.45B | ---- | -0.31%1.43B | ---- | 5.56%1.44B | ---- |
Net cash from operations | -41.45%872.87M | -29.56%2.5B | 2.68%1.49B | 42.48%3.55B | 1.20%1.45B | -7.36%2.49B | -0.31%1.43B | 5.36%2.69B | 5.56%1.44B | 45.63%2.56B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -10.33%58.18M | 42.00%146.48M | 25.38%64.88M | 26.02%103.15M | 104.09%51.74M | 34.12%81.85M | -2.65%25.35M | 45.32%61.03M | 48.64%26.04M | 61.06%42M |
Dividend received - investment | -1.21%68.26M | 338.12%137.16M | 120.71%69.09M | -33.72%31.31M | -33.72%31.31M | -32.64%47.24M | -32.64%47.24M | 186.49%70.13M | 186.48%70.13M | -9.12%24.48M |
Loan receivable (increase) decrease | ---- | ---- | ---- | -9.23%-34.82M | ---- | ---31.88M | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | -86.31%318K | ---- | -22.52%2.32M | ---- | 701.60%3M | ---- | -76.77%374K | ---- | 609.25%1.61M |
Purchase of fixed assets | 54.53%-4.33M | -49.92%-27.49M | -7.09%-9.52M | 21.46%-18.34M | 37.63%-8.89M | 37.84%-23.35M | 14.93%-14.26M | -0.03%-37.56M | 55.52%-16.76M | -10.90%-37.55M |
Purchase of intangible assets | -334.98%-456.61M | 42.66%-290.47M | -52.08%-104.97M | -213.69%-506.59M | 33.84%-69.02M | 46.85%-161.49M | 45.86%-104.33M | -0.31%-303.86M | -86.88%-192.71M | -977.38%-302.93M |
Sale of subsidiaries | ---- | ---11.16M | ---11.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---16.08M |
Acquisition of subsidiaries | ---- | ---- | -492.49%-116.3M | 53.41%-262.71M | 96.03%-19.63M | ---563.91M | ---493.83M | ---- | ---- | ---- |
Recovery of cash from investments | ---- | 572.27%20.34M | ---- | --3.03M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | -133.57%-299.22M | 0.85%-491.34M | 45.33%-128.11M | 43.10%-495.55M | -2.78%-234.32M | -455.04%-870.99M | -59.84%-227.98M | -257.87%-156.92M | -310.98%-142.63M | 81.01%-43.85M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.33%12.99M | ---- | --22.93M |
Adjustment items of investment business | ---- | --73.89M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -168.43%-633.72M | 62.46%-442.28M | 5.12%-236.08M | 22.46%-1.18B | 67.59%-248.81M | -329.46%-1.52B | -200.00%-767.81M | -14.36%-353.82M | -124.47%-255.93M | -29.08%-309.39M |
Net cash before financing | -80.94%239.15M | -13.24%2.06B | 4.29%1.25B | 143.76%2.38B | 80.42%1.2B | -58.33%974.33M | -43.64%666.8M | 4.12%2.34B | -5.29%1.18B | 48.25%2.25B |
Cash flow from financing activities | ||||||||||
New borrowing | -28.47%422M | -7.16%1.28B | 2.12%590M | 27.63%1.38B | -26.39%577.73M | 70.85%1.08B | 2.04%784.81M | --630.59M | --769.11M | ---- |
Refund | 46.37%-590M | -25.12%-1.79B | -94.32%-1.1B | -14,279,830.00%-1.43B | -77.81%-566.17M | 100.00%-10K | 59.45%-318.41M | 13.06%-696.94M | -2,143.37%-785.18M | -11.65%-801.6M |
Interest paid - financing | -45.80%-29.47M | -20.40%-45.21M | -63.76%-20.22M | -113.27%-37.55M | -82.46%-12.35M | 35.27%-17.61M | 34.41%-6.77M | 50.70%-27.2M | 57.26%-10.32M | 21.21%-55.18M |
Dividends paid - financing | 71.16%-191.99M | -12.38%-1.43B | -19.41%-665.8M | -10.51%-1.28B | -11.01%-557.59M | -38.45%-1.15B | -59.95%-502.31M | -1.38%-834.13M | 11.71%-314.03M | -12.94%-822.75M |
Absorb investment income | --2.79M | ---- | ---- | --33.09M | --33.09M | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---238.39M | -140.38%-116.3M | ---- | 68.07%-48.38M | ---42.38M | -74.23%-151.52M | ---- | ---86.96M | ---86.96M | ---- |
Other items of the financing business | 0.00%-1M | 0.00%-1M | 0.00%-1M | ---1M | 0.00%-1M | ---- | 88.75%-1M | -25.22%-9.81M | -0.58%-8.89M | 20.12%-7.83M |
Net cash from financing operations | 47.41%-633.92M | -51.80%-2.13B | -108.86%-1.21B | -441.78%-1.4B | -1,096.04%-577.14M | 75.02%-258.39M | 89.03%-48.25M | 38.97%-1.03B | -3.25%-439.8M | -9.06%-1.7B |
Effect of rate | -107.43%-1.91M | -105.62%-871K | 245.91%25.73M | 1,025.54%15.51M | 834.88%7.44M | 693.97%1.38M | -229.91%-1.01M | 65.32%-232K | 608.18%779K | 39.89%-669K |
Net Cash | -901.31%-394.78M | -106.61%-64.45M | -92.13%49.27M | 36.20%975.13M | 1.19%625.94M | -45.08%715.94M | -16.78%618.55M | 136.77%1.3B | -9.71%743.29M | 1,496.21%550.6M |
Begining period cash | -1.49%4.31B | 29.26%4.38B | 29.26%4.38B | 26.88%3.39B | 26.88%3.39B | 95.49%2.67B | 95.49%2.67B | 67.47%1.37B | 67.47%1.37B | -4.74%815.08M |
Cash at the end | -12.06%3.91B | -1.49%4.31B | 10.75%4.45B | 29.26%4.38B | 22.31%4.02B | 26.88%3.39B | 55.80%3.29B | 95.49%2.67B | 28.72%2.11B | 67.47%1.37B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.